Implementation of a Fast Healthcare Interoperability Resources-Based Clinical Decision Support Tool for Calculating CHADS-VASc Scores.
作者信息
Abedin Zameer, Hoerner Robert, Habboushe Joseph, Lu Yi, Kawamoto Kensaku, Warner Phillip B, Shields David E, Shah Rashmee U
机构信息
Department of Internal Medicine (Z.A., R.H.).
MDAware LLC (d/b/a MDCalc) (J.H., Y.L.).
出版信息
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006286. doi: 10.1161/CIRCOUTCOMES.119.006286. Epub 2020 Feb 6.
Abstract
摘要
相似文献
1
Implementation of a Fast Healthcare Interoperability Resources-Based Clinical Decision Support Tool for Calculating CHADS-VASc Scores.基于快速医疗保健互操作性资源的CHADS-VASc评分计算临床决策支持工具的实施
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006286. doi: 10.1161/CIRCOUTCOMES.119.006286. Epub 2020 Feb 6.
2
Recommendations on stroke prevention for patients having a CHADS-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines.2019年心房颤动指南中针对CHADS-VASc评分为1（男性）或2（女性）的患者的卒中预防建议。
Trends Cardiovasc Med. 2019 Oct;29(7):427-428. doi: 10.1016/j.tcm.2019.02.008. Epub 2019 Feb 25.
3
Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.心房颤动抗凝治疗预防卒中：临床医生决策与CHA2DS2-VASc及HAS-BLED评分之间的一致性评估
High Blood Press Cardiovasc Prev. 2018 Mar;25(1):61-64. doi: 10.1007/s40292-017-0237-9. Epub 2017 Oct 26.
4
SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.SUPPORT-AF II：通过心房颤动口服抗凝治疗的医疗服务提供者概况分析来支持抗凝剂的使用：一项关于电子概况分析和信息传递联合学术指导的群组随机研究，用于指导医疗服务提供者对心房颤动患者进行抗凝决策。
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e005871. doi: 10.1161/CIRCOUTCOMES.119.005871. Epub 2020 Feb 17.
5
Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?心房颤动的卒中风险：对于CHA2DS2-VASc评分≥1分或更高的患者，我们是采用CHADS2评分还是CHA2DS2-VASc评分来指导抗凝治疗？
Thromb Haemost. 2015 Jun;113(6):1165-9. doi: 10.1160/TH15-02-0154. Epub 2015 Mar 6.
6
Electronic Decision support for Improvement of Contemporary Therapy for Stroke Prevention.用于改善当代卒中预防治疗的电子决策支持
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):569-573. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.041. Epub 2018 Nov 22.
7
Augmented intelligence decision tool for stroke prediction combines factors from CHA DS -VASc and the intermountain risk score for patients with atrial fibrillation.增强型人工智能决策工具用于预测中风，结合了 CHA2DS2-VASc 和房颤患者的山间风险评分的因素。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1452-1461. doi: 10.1111/jce.13999. Epub 2019 Jun 25.
8
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.非瓣膜性心房颤动且 CHA2DS2-VASc 评分为 1 分的患者的口服抗凝治疗：欧洲心脏病学会心血管药物治疗工作组和欧洲心脏病学会卒中委员会的当前观点。
Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp/pvz016.
9
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.利伐沙班与华法林在非瓣膜性心房颤动伴非性别相关 CHA2DS2-VASc 评分为 1 分患者中的有效性和安全性。
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):64-69. doi: 10.1093/ehjcvp/pvy025.
10
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.CHADS2与CHA2DS2-VASc对心房颤动患者独立于抗凝治疗的中风和血栓栓塞预测的荟萃分析。
Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb.
引用本文的文献
1
Effects of machine learning-based clinical decision support systems on decision-making, care delivery, and patient outcomes: a scoping review.基于机器学习的临床决策支持系统对决策制定、护理提供和患者结局的影响：范围综述。
J Am Med Inform Assoc. 2023 Nov 17;30(12):2050-2063. doi: 10.1093/jamia/ocad180.
2
GARDE: a standards-based clinical decision support platform for identifying population health management cohorts.GARDE：一个基于标准的临床决策支持平台，用于识别人群健康管理队列。
J Am Med Inform Assoc. 2022 Apr 13;29(5):928-936. doi: 10.1093/jamia/ocac028.
3
Evaluation in Life Cycle of Information Technology (ELICIT) framework: Supporting the innovation life cycle from business case assessment to summative evaluation.信息技术全生命周期评估（ELICIT）框架：支持从商业案例评估到总结性评估的创新生命周期。
J Biomed Inform. 2022 Mar;127:104014. doi: 10.1016/j.jbi.2022.104014. Epub 2022 Feb 12.
4
New Standards for Clinical Decision Support: A Survey of The State of Implementation.临床决策支持新规范：实施现状调查。
Yearb Med Inform. 2021 Aug;30(1):159-171. doi: 10.1055/s-0041-1726502. Epub 2021 Sep 3.
5
Establishing a multidisciplinary initiative for interoperable electronic health record innovations at an academic medical center.在一所学术医疗中心建立一个针对可互操作电子健康记录创新的多学科倡议。
JAMIA Open. 2021 Jul 31;4(3):ooab041. doi: 10.1093/jamiaopen/ooab041. eCollection 2021 Jul.
6
Importance of clinical decision support system response time monitoring: a case report.临床决策支持系统响应时间监测的重要性：案例报告。
J Am Med Inform Assoc. 2019 Nov 1;26(11):1375-1378. doi: 10.1093/jamia/ocz133.
本文引用的文献
1
Association of an Electronic Health Record Add-on App for Neonatal Bilirubin Management With Physician Efficiency and Care Quality.电子病历附加应用程序对新生儿胆红素管理与医生效率和护理质量的关联。
JAMA Netw Open. 2019 Nov 1;2(11):e1915343. doi: 10.1001/jamanetworkopen.2019.15343.
2
Electronic Decision support for Improvement of Contemporary Therapy for Stroke Prevention.用于改善当代卒中预防治疗的电子决策支持
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):569-573. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.041. Epub 2018 Nov 22.
3
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):e199-267. doi: 10.1161/CIR.0000000000000041. Epub 2014 Mar 28.
4
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.采用新型基于风险因素的方法对房颤患者的卒中与血栓栓塞风险进行临床分层的研究：房颤的欧洲心脏调查。
Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
Zotero 插件